10-Q: ESG Inc. Reports Q1 2026 Results Amidst Operational Suspension
Quarterly Report
ESG Inc. filed its Q1 2026 10-Q, reporting no revenue for the quarter due to the continued suspension of its China mushroom operations, while pursuing a strategic shift towards North America.
Summary
- ESG Inc. reported no revenue for the first quarter of 2026, a significant decrease from $1,587,144 in the same period of 2025, due to the ongoing suspension of its PRC mushroom operations.
- Operating expenses increased by 172.0% to $787,081 in Q1 2026 from $289,330 in Q1 2025, largely due to the classification of depreciation as SG&A during the production suspension and ongoing public company costs.
- The company reported a net loss of $884,050 for Q1 2026, compared to a net loss of $276,153 for Q1 2025.
- As of March 31, 2026, the company had $206,391 in cash and a working capital deficiency of approximately $6.9 million, raising substantial doubt about its ability to continue as a going concern.
- A subsequent event on April 10, 2026, involved a Split-Off and Share Exchange Agreement for the proposed divestiture of ESG China Limited and its China operations.
- The company is actively pursuing additional financing and business development, including North America product commercialization, to address its liquidity concerns.
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a very negative filing due to the complete absence of revenue, significant increase in net loss, and severe liquidity concerns, despite the proposed divestiture of China operations and pivot to North America.
Positives
- The company secured $200,000 in aggregate gross proceeds from convertible note financings in Q1 2026.
- There was a decrease in net cash used in operating activities to $708,659 in Q1 2026 from $1,625,425 in Q1 2025, primarily due to lower accounts payable reductions.
- No capital expenditures were made in Q1 2026, reducing cash outflow from investing activities to $0 compared to $88,321 in Q1 2025.
- The company is actively pursuing strategic repositioning towards North America food operations and product commercialization.
Negatives
- Revenue for the three months ended March 31, 2026, was $0, a complete drop from $1,587,144 in the prior year period.
- Gross profit was $0 for Q1 2026, compared to $80,932 in Q1 2025.
- The company reported a net loss of $884,050 for Q1 2026, an increase from the $276,153 loss in Q1 2025.
- As of March 31, 2026, the company had a working capital deficiency of approximately $6.9 million.
- The company's cash balance of $206,391 as of March 31, 2026, is not expected to be sufficient to fund operations and obligations for the next twelve months.
- Disclosure controls and procedures were not effective as of March 31, 2026.
Risks
- The company's ability to continue as a going concern is subject to substantial doubt due to limited cash, recurring losses, and a working capital deficiency.
- The suspension of PRC mushroom operations and related liquidity constraints have materially affected the company's results and cash flows.
- The proposed split-off of China operations, if consummated, would significantly reduce the company's historical operating assets, liabilities, and revenue-generating activities, making it substantially dependent on North America operations and additional financing.
- There is no assurance that financing efforts or business development activities, including North America product commercialization, will be successful.
- The collectability and timing of collection of accounts receivable are subject to customer payment performance and the operating and liquidity conditions of the PRC business.
- The company's PRC operating subsidiaries and affiliates are involved in supplier and contract payment disputes arising from liquidity constraints.
Future Outlook
The company is pursuing additional financing and business development activities, including North America product commercialization initiatives. However, there can be no assurance that such efforts will be successful. The company expects to reassess the accounting presentation of its China operations in future reporting periods if the proposed split-off transaction satisfies applicable accounting criteria.
Management Comments
- Management believes the liabilities related to supplier and contract payment disputes have been accrued, continues to monitor compliance with applicable settlements and judgments, and is evaluating any further enforcement exposure.
- Management concluded that the disclosure controls and procedures were not effective as of March 31, 2026.
- Management is pursuing additional financing and business development activities, including North America product commercialization initiatives, but there can be no assurance that such efforts will be successful.
Industry Context
StockSavvy.ai notes that ESG Inc.'s Q1 2026 results reflect significant challenges in the mushroom industry, particularly concerning the suspension of operations in China. The company's pivot towards North America and its focus on alternative protein products align with broader industry trends towards plant-based and sustainable food solutions. However, the severe liquidity constraints and the pending divestiture of its China operations highlight substantial execution risks.
Comparison to Industry Standards
- The company's revenue of $0 for Q1 2026 is significantly below industry averages for companies operating in the food and agriculture sectors, which typically report consistent revenue streams.
- The substantial net loss and working capital deficiency are concerning when compared to established players in the mushroom cultivation and processing industry, who generally maintain positive net income and healthy working capital.
- The company's reliance on convertible notes and warrants for financing is a common strategy for early-stage or distressed companies, but it carries higher dilution risk compared to traditional debt or equity offerings used by more stable industry participants.
- The suspension of operations in China, a major global hub for mushroom production, contrasts with industry trends focused on expanding production capacity and market reach.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Disclosure Controls and Procedures | Management concluded that the company's disclosure controls and procedures were not effective as of March 31, 2026. | 2026-03-31 | Indicates potential weaknesses in the company's ability to ensure timely and accurate disclosure of material information. |
Legal Proceedings
- The company's PRC operating subsidiaries and affiliates have been involved in several supplier and contract payment disputes arising from unpaid amounts owed to vendors following the suspension of PRC mushroom operations and related liquidity constraints.
- These matters primarily relate to raw material, straw, construction, deposit refund, and similar operating payables, several of which have been resolved by court-mediated settlements, judgments, or staged payment arrangements.
Related Party Transactions
- As of March 31, 2026, the Company had $4,534,269 of other payables, including $1,740,467 of loans and related interest from Funan Agricultural Investment Co., Ltd. and Funan Business Financing Service Center, and $1,451,840 of amounts payable to the owner of Funan Zhihua Mushroom Co., Ltd.
- As of December 31, 2025, the Company had $4,366,441 of other payables, including $1,970,940 of loans and related interest from Funan Agricultural Investment Co. Ltd and Funan Business Financing Service Center, and $555,882 of payable to the owner of Funan Zhihua Mushroom Co., Ltd.
Stakeholder Impact
- Shareholders: Potential for significant dilution from future financing, uncertainty regarding the success of the China split-off and North America pivot, and ongoing going concern risks.
- Creditors: Increased risk due to the company's liquidity challenges and working capital deficiency.
- Suppliers: Potential for continued payment disputes and delays due to the company's financial condition.
- Employees: Uncertainty regarding job security and company operations, especially with the suspension of PRC operations and strategic shifts.
Next Steps
- Complete the proposed split-off of ESG China Limited and the Company's China operations.
- Continue pursuing additional financing through debt, equity, or strategic transactions.
- Advance North America product commercialization initiatives.
- Evaluate the accounting presentation of China operations as discontinued operations if the split-off criteria are met.
Key Dates
| Date | Description |
|---|---|
| 2025-08-01 | Issuance of convertible promissory note to Labrys Fund II, L.P. |
| 2025-08-05 | Issuance of convertible promissory note to Labrys Fund II, L.P. |
| 2025-12-31 | Audited financial statements for the year ended December 31, 2025. |
| 2026-01-01 | Beginning of the first quarter of 2026. |
| 2026-02-01 | Labrys Note conversion period start. |
| 2026-02-06 | Holder of Labrys note converted accrued interest and fees into common stock. |
| 2026-03-01 | Monroe Street Capital Partners, LP convertible note issuance period start. |
| 2026-03-06 | Issuance of convertible promissory note to Monroe Street Capital Partners, LP. |
| 2026-03-01 | Crom Structured Opportunities Fund I, LP convertible note issuance period start. |
| 2026-03-09 | Issuance of convertible promissory note to Crom Structured Opportunities Fund I, LP. |
| 2026-03-31 | End of the first quarter of 2026. Balance sheet date. |
| 2026-04-01 | Labrys Note conversion period end. |
| 2026-04-10 | Company entered into a Split-Off and Share Exchange Agreement for China operations. |
| 2026-04-13 | Holder of Labrys note converted accrued interest and fees into common stock. |
| 2026-05-14 | Date as of which the number of common shares outstanding was reported. |
| 2026-05-15 | Date of the report filing. |
Recommendation
sellThe company faces severe liquidity issues, a complete lack of revenue in the current quarter, and a significant increase in net loss. While a strategic shift and potential divestiture are underway, the going concern risk is substantial, and future financing is uncertain. These factors present a high degree of risk for investors.
Keywords
ESG Inc., 10-Q, Quarterly Report, Financial Statements, Results of Operations, Going Concern, Liquidity, China Operations, Split-off, North America Operations, Mushroom, Financing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.